{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T19:48:57Z","timestamp":1769456937795,"version":"3.49.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"40","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["OPP1115556"],"award-info":[{"award-number":["OPP1115556"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.vaccine.2022.08.034","type":"journal-article","created":{"date-parts":[[2022,9,2]],"date-time":"2022-09-02T23:55:30Z","timestamp":1662162930000},"page":"5828-5834","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Immune non-interference and safety study of Vi-DT typhoid conjugate vaccine with a measles, mumps and rubella containing vaccine in 9\u201315\u00a0months old Nepalese infants"],"prefix":"10.1016","volume":"40","author":[{"given":"Tarun","family":"Saluja","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ganesh Kumar","family":"Rai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shipra","family":"Chaudhary","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Piush","family":"Kanodia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bishnu Rath","family":"Giri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deok Ryun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jae Seung","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Il-Yeon","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seung-Eun","family":"Kyung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sridhar","family":"Vemula","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jagadeesh","family":"Reddy E","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bomi","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Birendra Prasad","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sue Kyoung","family":"Jo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ji Hwa","family":"Ryu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ho Keun","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jong Hoon","family":"Shin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoonyeong","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jerome H.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zenaida Reynoso","family":"Mojares","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T. Anh","family":"Wartel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sushant","family":"Sahastrabuddhe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2022.08.034_b0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pntd.0004616","article-title":"The burden of typhoid and paratyphoid in India: systematic review and meta-analysis","volume":"10","author":"John","year":"2016","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2022.08.034_b0010","unstructured":"GBD 2017 Typhoid and Paratyphoid Collaborators.The global burden of typhoid and paratyphoid fevers: a systematic analysis for the Global Burden of Disease Study 2017. The Lancet Infectious Diseases. 2019. doi:10.1016\/ S1473-3099(18)30685-6."},{"issue":"Suppl 6","key":"10.1016\/j.vaccine.2022.08.034_b0015","doi-asserted-by":"crossref","first-page":"S499","DOI":"10.1093\/cid\/ciz705","article-title":"Spatial and temporal patterns of typhoid and paratyphoid fever outbreaks: a worldwide review, 1990\u20132018","volume":"69","author":"Kim","year":"2019","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2022.08.034_b0020","unstructured":"Background Paper on Typhoid Vaccines for SAGE Meeting (October 2017) http:\/\/www.who.int\/immunization\/sage\/meetings\/2017\/october\/1_Typhoid_SAGE_background_paper_Final_v3B.pdf. accessed 22nd February 2019."},{"key":"10.1016\/j.vaccine.2022.08.034_b0025","first-page":"346","article-title":"The global burden of typhoid fever","volume":"82","author":"Crump","year":"2004","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.vaccine.2022.08.034_b0030","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1086\/649541","article-title":"Global trends in typhoid and paratyphoid fever","volume":"50","author":"Crump","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2022.08.034_b0035","series-title":"Nelson textbook of pediatrics","first-page":"948","article-title":"Salmonella","author":"Buttha","year":"2011"},{"key":"10.1016\/j.vaccine.2022.08.034_b0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7189\/jogh.01.010401","article-title":"Typhoid fever and paratyphoid fever: Systematic review to estimate global morbidity and mortality for 2010","volume":"2","author":"Buckle","year":"2012","journal-title":"J Global Health"},{"key":"10.1016\/j.vaccine.2022.08.034_b0045","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S1473-3099(13)70241-X","article-title":"Immunogenecity and safety of the Vi-CRM197 conjugate vaccine against typhoid fever in adult, children, and infants in south and southeast Asia: results from two randomised, observer-blind, age de-escalation, phase 2 trials","volume":"14","author":"Bhutta","year":"2014","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2022.08.034_b0050","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1097\/INF.0b013e3181e39f8b","article-title":"Incidence of typhoid bacteremia in infants and young children in southern coastal Pakistan","volume":"29","author":"Owais","year":"2010","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2022.08.034_b0055","doi-asserted-by":"crossref","unstructured":"Lin FYC, Ho VA, Khiem HB, Trach DD, Bay PV, Thanh TC, et al. The efficacy of Salmonella typhi Vi conjugate vaccine in two-to-five-year-old children. N Engl J Med. 2001; 344:1263\u20139. 10. 1056\/NEJM200104263441701 PMID: 11320385.","DOI":"10.1056\/NEJM200104263441701"},{"key":"10.1016\/j.vaccine.2022.08.034_b0060","doi-asserted-by":"crossref","first-page":"260","DOI":"10.2471\/BLT.06.039818","article-title":"A study of typhoid fever in five Asian countries: disease burden and implications for controls","volume":"86","author":"Ochiai","year":"2008","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.vaccine.2022.08.034_b0065","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1093\/jac\/dkl391","article-title":"Molecular characterization of ciprofloxacin-resistant Salmonella enterica serovar Typhi and Paratyphi A causing enteric fever in India","volume":"58","author":"Gaind","year":"2006","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.vaccine.2022.08.034_b0070","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/S1473-3099(15)00530-7","article-title":"Gatifloxcain versus ceftriaxone for uncomplicated enteric fever in Nepal: an open-label, two-centre, randomised controlled trial","volume":"16","author":"Arjyal","year":"2016","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2022.08.034_b0075","doi-asserted-by":"crossref","first-page":"879","DOI":"10.3201\/eid1605.091917","article-title":"Fluoroquinolone-resistant typhoid","volume":"16","author":"Keddy","year":"2010","journal-title":"South Africa Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2022.08.034_b0080","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0001921","article-title":"Salmonella Typhi in the Democratic Republic of the Congo: fluoroquinolone decreased susceptibility on the rise","volume":"6","author":"Lunguya","year":"2012","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2022.08.034_b0085","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1128\/CMR.00002-15","article-title":"Epidemiology, clinical presentation, laboratory diagnosis, antimicrobial resistance and antimicrobial management of invasive Salmonella infections","volume":"28","author":"Crump","year":"2015","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.vaccine.2022.08.034_b0090","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1016\/S0140-6736(13)62708-7","article-title":"Typhoid fever","volume":"385","author":"Wain","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2022.08.034_b0095","unstructured":"Yousafzai MT, Qamar FN, Shakoor S, Saleem K,Kazi M,Garett D, et al. Outbreak investigation of cefriaxone resistant S. Typhi in Hyderabad, Pakistan. 10th International Conference on Typhoid and other Invasive Salmonellosis. April 4-6,2017. Kampala, Uganda."},{"key":"10.1016\/j.vaccine.2022.08.034_b0100","unstructured":"Typhoid Fact Sheet 2020. : https:\/\/www.coalitionagainsttyphoid.org\/wp-content\/uploads\/2020\/07\/Typhoid-fact-sheet_June-2020.pdf."},{"key":"10.1016\/j.vaccine.2022.08.034_b0105","unstructured":"Measles \u2014 global situation.2019. https:\/\/www.who.int\/csr\/don\/26-november-2019-measles-global_situation\/en\/."},{"key":"10.1016\/j.vaccine.2022.08.034_b0110","volume":"6100074","author":"Capeding","year":"2020","journal-title":"Vaccine X"},{"key":"10.1016\/j.vaccine.2022.08.034_b0115","article-title":"Seroprevalence of Measles-, Mumps-, and Rubella-specific antibodies in the German adult population cross-sectional analysis of the German Health Interview and Examination Survey for Adults (DEGS1)","volume":"7","author":"Friedrich","year":"2021","journal-title":"The Lancet Regional Health-Eur"},{"key":"10.1016\/j.vaccine.2022.08.034_b0120","unstructured":"Global burden of 369 diseases and injuries in 204 countries and territories, 1990\u20132019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020; 396: 1204-1222."},{"key":"10.1016\/j.vaccine.2022.08.034_b0125","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1093\/cid\/civ295","article-title":"Safety and immunogenicity of a Vi polysaccharide-tetanus toxoid conjugate vaccine (Typbar TCV\u00ae) in healthy infants, children, and adults in typhoid endemic areas: a multicenter, 2-cohort, open-label, double-blind, randomized controlled phase 3 study","volume":"61","author":"Mohan","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2022.08.034_b0130","doi-asserted-by":"crossref","first-page":"3518","DOI":"10.1016\/j.vaccine.2020.03.028","article-title":"Adverse events following immunization with typhoid conjugate vaccine in an outbreak setting in Hyderabad","volume":"38","author":"Qamar","year":"2020","journal-title":"Pakistan Vaccine"},{"issue":"23","key":"10.1016\/j.vaccine.2022.08.034_b0135","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1056\/NEJMoa1905047","article-title":"Phase 3 efficacy analysis of a typhoid conjugate vaccine trial in nepal","volume":"381","author":"Shakya","year":"2019","journal-title":"The New England j med"},{"key":"10.1016\/j.vaccine.2022.08.034_b0140","article-title":"Safety and immunogenicity of co-administration of meningococcal type a and measles rubella vaccines with typhoid conjugate vaccine in children aged 15\u201323 months in Burkina Faso","author":"Sirima","year":"2020","journal-title":"Int J Infect Dis"},{"issue":"28","key":"10.1016\/j.vaccine.2022.08.034_b0145","doi-asserted-by":"crossref","first-page":"4476","DOI":"10.1016\/j.vaccine.2019.09.074","article-title":"Immunogenicity, safety and reactogenicity of a Phase II trial of Vi-DT typhoid conjugate vaccine in healthy Filipino infants and toddlers: a preliminary report","volume":"38","author":"Capeding","year":"2020","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2022.08.034_b0150","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1016\/S0140-6736(17)32149-9","article-title":"Efficacy and immunogenicity of a Vi-tetanus toxoid conjugate vaccine in the prevention of typhoid fever using a controlled human infection model of Salmonella Typhi: a randomised controlled, phase 2b trial","volume":"390","author":"Jin","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2022.08.034_b0155","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000001721","article-title":"Combination measles-mumps-rubella-varicella vaccine in healthy children: a systematic review and meta-analysis of immunogenicity and safety","volume":"94","author":"Ma","year":"2015","journal-title":"Med (Baltimore)"},{"key":"10.1016\/j.vaccine.2022.08.034_b0160","article-title":"Vaccines for preventing typhoid fever","volume":"5Cd001261","author":"Milligan","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.vaccine.2022.08.034_b0165","article-title":"Safety and immunogenicity of Vi-DT conjugate vaccine among 6\u201323-month-old children: Phase II, randomized, dose-scheduling, observer-blind Study","volume":"27","author":"Capeding","year":"2020","journal-title":"EClinicalMedicine (Lancet)"},{"key":"10.1016\/j.vaccine.2022.08.034_b0170","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1007\/s13312-020-1890-y","article-title":"Immunogenicity and safety of typhoid conjugate vaccine in healthy Indian subjects: a randomized, active-controlled, comparative clinical trial","volume":"57","author":"Kundu","year":"2020","journal-title":"Indian Pediatr"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X2201009X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X2201009X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T11:15:41Z","timestamp":1759403741000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X2201009X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":34,"journal-issue":{"issue":"40","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["S0264410X2201009X"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2022.08.034","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immune non-interference and safety study of Vi-DT typhoid conjugate vaccine with a measles, mumps and rubella containing vaccine in 9\u201315\u00a0months old Nepalese infants","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2022.08.034","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}